Lipitab 2 mg (Pitavastatin Calcium Hydrate)

Adult dose

For adults, the usual initial dose of pitavastatin calcium is 1-2 mg once daily. If the cholesterol-lowering effect on LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg per day. The dosage should be adjusted appropriately at intervals of 4 weeks or more, depending on LDL cholesterol levels, therapeutic goals, and patient response.

This medication should not be administered to certain patients. It should not be used in patients who are allergic to any component of this medication, patients with liver function issues or severe liver diseases, and those with bile flow obstruction. Additionally, it should not be given to patients taking cyclosporine, patients with myopathy, pregnant or potentially pregnant women, nursing mothers, and children. Patients with renal dysfunction or a history of liver disorders, those excessively consuming alcohol, and those taking certain medications should use this medication cautiously. In particular, caution is necessary when taken with fibrate agents or niacin, as there is a higher risk of muscle damage and renal function deterioration. During the use of this medication, abnormal symptoms such as muscle pain, weakness, abdominal pain, rash, and itching may occur. Liver function abnormalities, abnormal blood test results, and rarely, severe muscle damage known as rhabdomyolysis may occur, so any unusual symptoms should be immediately discussed with a physician. As this medication is mainly metabolized in the liver, regular liver function tests should be conducted, and if liver function worsens, the medication should be discontinued. Moreover, treatment should be stopped, and a physician should be consulted if symptoms such as muscle pain or muscle weakness appear. This medication should not be administered to pregnant or nursing women, and women of childbearing potential must confirm pregnancy status before taking it. This medication may interact with other drugs, so it is important to notify your doctor or pharmacist of any other medications you are taking. Particular caution is required when taken in combination with cyclosporine, fibrate drugs, niacin, and erythromycin. Elderly patients may experience side effects more easily due to reduced body function, so dosage adjustments and caution are necessary. This medication has not been established for safety and efficacy in children, and therefore should not be used in this population. Lastly, this medication should be stored in its original container and kept out of reach of children, as transferring it to another container may pose risks of accidents or quality deterioration.

Serious side effects

• Urticaria
• rhabdomyolysis
• severe swelling
• severe allergic reactions
• liver dysfunction
• jaundice
• thrombocytopenia
• myopathy
• acute renal failure
• deteriorated kidney function

Mild side effects

• Abdominal pain
• rash
• fatigue
• numbness
• itching
• stiffness
• drowsiness
• insomnia
• headache
• heaviness in the head

This medication is sensitive to light and should be stored in a special container that does not allow light to enter. Additionally, it is best to store the medication at room temperature, between 1°C and 30°C, avoiding very hot or very cold areas.

Appearance

Very light yellowish-red round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle